Explore ›
Finding
Finding
decline
Pediatric APL patients with FLT3 mutations had a dramatically higher rate of high diagnostic WBC count (>10,000 cells/uL) at 70% compared to 26% in FLT3 wild-type patients, with median WBC of 32,950 vs 3,600 cells/uL.
| Effect size | 70% vs 26% |
| Comparator | FLT3 wild-type (FLT3/WT) pediatric APL patients on CALGB C9710 |
| Effect summary | decline; 70% vs 26% |
Connected entities
Interventions
Outcomes
Populations
Source
PMC3368997
FLT3 Mutation Status is a Predictor of Early Death in Pediatric Acute Promyelocytic Leukemia: A Report From The Children's Oncology Group